Form 4 for RGEN REPLIGEN CORP
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-17 · accession 0001193125-25-324912 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | 2025-12-17 | RGEN | DAWES KAREN A | Dir | S - Sale | $161.00 | -275 | 91.8K | -0.3% | -$44.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-17 | S | D | 275 | $161.00 | 91,821 | D | — | — |